WuXi AppTec's Unit to Sell Shareholding in U.S., UK Operating Entities for Cash Consideration

MT Newswires Live

2024/12/26

WuXi AppTec's (HKG:2359, SHA:603259) subsidiaries WuXi ATU (Ireland) Holding and WuXi ATU (Hong Kong) agreed to sell all the shares held by them in the WuXi Advanced Therapies and Oxford Genetics to Altaris for cash consideration, a Tuesday Hong Kong bourse filing said.

Altaris is a medical healthcare industry-focused equity investment fund based in the U.S.A., while WuXi Advanced Therapies and Oxford Genetics are U.S. and United Kingdom operating entities of the WuXi ATU business.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2494524588"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2494524588\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2494524588?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-26 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2494524588","market":"us","top_or_hot":-1,"title":"WuXi AppTec's Unit to Sell Shareholding in U.S., UK Operating Entities for Cash Consideration","media":"MT Newswires Live","content":"<html><body><p> WuXi AppTec's (HKG:2359, SHA:603259) subsidiaries WuXi ATU (Ireland) Holding and WuXi ATU (Hong Kong) agreed to sell all the shares held by them in the WuXi Advanced Therapies and Oxford Genetics to Altaris for cash consideration, a Tuesday Hong Kong bourse filing said.</p><p>Altaris is a medical healthcare industry-focused equity investment fund based in the U.S.A., while WuXi Advanced Therapies and Oxford Genetics are U.S. and United Kingdom operating entities of the WuXi ATU business.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WuXi AppTec's Unit to Sell Shareholding in U.S., UK Operating Entities for Cash Consideration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuXi AppTec's Unit to Sell Shareholding in U.S., UK Operating Entities for Cash Consideration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-26 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> WuXi AppTec's (HKG:2359, SHA:603259) subsidiaries WuXi ATU (Ireland) Holding and WuXi ATU (Hong Kong) agreed to sell all the shares held by them in the WuXi Advanced Therapies and Oxford Genetics to Altaris for cash consideration, a Tuesday Hong Kong bourse filing said.</p><p>Altaris is a medical healthcare industry-focused equity investment fund based in the U.S.A., while WuXi Advanced Therapies and Oxford Genetics are U.S. and United Kingdom operating entities of the WuXi ATU business.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02359","symbol_name":"药明康德","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2494524588","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2494524588","pubTimestamp":1735216963,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"WuXi AppTec's  subsidiaries WuXi ATU  Holding and WuXi ATU  agreed to sell all the shares held by them in the WuXi Advanced Therapies and Oxford Genetics to Altaris for cash consideration, a Tuesday Hong Kong bourse filing said.Altaris is a medical healthcare industry-focused equity investment fund based in the U.S.A., while WuXi Advanced Therapies and Oxford Genetics are U.S. and United Kingdom operating entities of the WuXi ATU business.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"02359":"药明康德"},"translate_title":"药明康德旗下子公司将以现金对价出售美国和英国运营实体的股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":0.9},"content_text":"WuXi AppTec's (HKG:2359, SHA:603259) subsidiaries WuXi ATU (Ireland) Holding and WuXi ATU (Hong Kong) agreed to sell all the shares held by them in the WuXi Advanced Therapies and Oxford Genetics to Altaris for cash consideration, a Tuesday Hong Kong bourse filing said.Altaris is a medical healthcare industry-focused equity investment fund based in the U.S.A., while WuXi Advanced Therapies and Oxford Genetics are U.S. and United Kingdom operating entities of the WuXi ATU business.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}